---
name: Pilot Patient AW Age 26

data:
- 
  resourceType: Patient
  name: Amanda17 Wallonia44
  gender: female
  birthDate: 1997-06-01
  id: Amanda17 Wallonia44
  extension:
  -
    url: http://hl7.org/fhir/us/core/StructureDefinition/us-core-birthsex
    valueCode: F

# CIN 2 Pathology
-
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - SNOMEDCT#285838002 Cervical intraepithelial neoplasia grade 2 (disorder)
  effectiveDateTime: 2023-06-03

# Colposcopy Procedure
-
  resourceType: Procedure
  code: CPT#57455 Colposcopy of the cervix including upper/adjacent vagina; with biopsy(s) of the cervix
  performedDateTime: 2023-06-03
  status: completed
  
# ASC-US Pap and HR HPV+
- 
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - SNOMEDCT#441087007 Atypical squamous cells of undetermined significance on cervical Papanicolaou smear (finding)
  effectiveDateTime: 2023-04-25
- 
  resourceType: DiagnosticReport
  code: LOINC#21440-3 Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe
  status: final
  conclusionCode:
  - SNOMEDCT#720005005 Human papillomavirus deoxyribonucleic acid test positive, high risk on cervical specimen (finding)
  effectiveDateTime: 2023-04-25


# ASC-US Pap
- 
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - SNOMEDCT#441087007 Atypical squamous cells of undetermined significance on cervical Papanicolaou smear (finding)
  effectiveDateTime: 2022-02-21


# Unsatisfactory Pap Smear
- 
  resourceType: DiagnosticReport
  code: LOINC#47527-7 Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep
  status: amended
  conclusionCode:
  - SNOMEDCT#126481000119106 Vaginal Papanicolaou smear unsatisfactory for evaluation (finding)
  effectiveDateTime: 2019-03-07

results:
  ManagementRecommendation: 
    short: 'Surveillance or Treatment'
    date: '2023-12-30'
    group: 'Managing Histology (I.2)'
    details: 
    - "Treatment of CIN2 is recommended unless the patient's concerns about the effect of treatment on future pregnancy outweigh concerns about cancer."
    - 'Excisional treatment is preferred, and treatment with ablation is acceptable.'
    - 'Observation is unacceptable when the squamocolumnar junction or the upper limit of the lesion is not fully visualized or when the results of an endocervical sampling, if performed, is CIN 2+ or ungraded.'
    - 'Observation includes colposcopy and primary hrHPV testing or cotesting at 6-month intervals for up to 2 years.'


